R

Repligen Corp
D

RGEN

142.980
USD
1.21
(0.85%)
Market Open
Volume
4,492
EPS
1
Div Yield
-
P/E
-4,758
Market Cap
7,997,814,994
OverviewSignalsIdeasNews
Related Instruments
    A
    ALLO
    -0.19000
    (-7.71%)
    2.27500 USD
    A
    ARCT
    -2.310
    (-12.60%)
    16.020 USD
    A
    ARWR
    -2.890
    (-13.49%)
    18.540 USD
    C
    CRSP
    0.360
    (0.77%)
    47.280 USD
    E
    EDIT
    -0.11500
    (-4.14%)
    2.66500 USD
    F
    FATE
    -0.04500
    (-2.17%)
    2.02500 USD
    N
    NSTG
    0
    (0%)
    0.000000 USD
    N
    NVTA
    0
    (0%)
    0.000000 USD
    S
    SGMO
    -0.10000
    (-4.67%)
    2.04000 USD
    V
    VCYT
    -1.085
    (-2.93%)
    35.955 USD
    More
News

Title: Repligen Corp

Sector: Healthcare
Industry: Medical Instruments & Supplies
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.